Two papers on Embil's novel triple-active topical products (Neo-Penotran® Forte and Neo-Penotran® Forte-L) have been accepted for presentation at the 4'th World Conference on Vaginitis, Costa Rica, 10-13 Jan 2004 More
APR has patented a new process and technology for the preparation of granulates containing liposoluble and hydrphobic drugs, preferably Megestrol Acetate, which shows a rapid, stable water dispersibility without precipitation or flocculation. More
Foamix is partnering with leading phamaceutical companies in developing their drugs in foam formulations. The company will present at the upcoming American Academy of Dermatology meeting in New Orleans on February 18-22, 2005 More
Morphochem and GBF have entered into a research collaboration in the area of cancer research, the objective of which is to develop new therapeutics using tubulysins. More
First and Only Water-Optional Handwash Helps Fight Nosocomial Infections in Hospitals; Helps Standardize Hospital Handwashing, Increases Efficacy, Improves Handwashing Compliance More